Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemiaJOURNAL OF CLINICAL LIPIDOLOGYIF4.62024-03-012OAAI
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional StudyFRONTIERS IN MEDICINEIF32022-05-039OAAI
PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive CardiologyCURRENT ATHEROSCLEROSIS REPORTSIF5.22022-03-2510OAAI
THE EFFECTIVENESS OF LIFE-STYLE COUNSELLING IN PATIENTS WITH ATHEROGENIC DYSLIPIDEMIA ON LIPID PROFILE AND ATHEROSCLEROSIS RISKATHEROSCLEROSISIF5.72019-08-010PREAI
PLASMOCELLULAR MYELOMA AS A CAUSE OF SEVERE MIXED DYSLIPIDEMIA ACCOMPANIED BY HYPERVISCOSITY SYNDROMEATHEROSCLEROSISIF5.72019-08-010PREAI
Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registryATHEROSCLEROSISIF5.72018-10-0123PREAI
FAMILIAL DYSBETALIPOPROTEINEMIA - YES, OR NO? - RETROSPECTIVE PATIENT STUDY OF THE CENTER FOR PREVENTIVE CARDIOLOGY OF THE 3RD INTERNAL CLINIC FIRST FACULTY OF MEDICINE AND GENERAL UNIVERSITY HOSPITALATHEROSCLEROSISIF5.72018-08-010PREAI